TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	94.22	103.58	300.15	554.7	113.89	43.2	57.31	25.61	55.64	56.29	Upgrade
Short-Term Investments	124.58	59.37	15.88	51.99	27.8	26.94	28	19.85	22.17	23.06	Upgrade
Cash & Cash Equivalents	218.79	162.95	316.03	606.69	141.69	70.14	85.3	45.47	77.81	79.35	Upgrade
Cash Growth	34.27%	-48.44%	-47.91%	328.19%	102.00%	-17.77%	87.61%	-41.56%	-1.95%	96.00%	Upgrade
Receivables	51.09	0	1.39	0	0	0	0	0	0	0	Upgrade
Inventory	39.82	0	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	8.23	5.32	13.55	5.06	7.47	8.89	8.01	5.4	9.07	5.86	Upgrade
Total Current Assets	317.94	168.27	330.97	611.74	149.15	79.03	93.32	50.86	86.87	85.22	Upgrade
Property, Plant & Equipment	9.56	10.82	11.07	11.84	11.81	2.55	2.68	2.37	0.05	0.02	Upgrade
Long-Term Investments	0	12.4	35.53	0	0	0	0	0	25	0	Upgrade
Goodwill and Intangibles	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	Upgrade
Other Long-Term Assets	1.29	1.27	1.26	1.26	1.25	1.24	0.59	0.75	0.75	0.71	Upgrade
Total Long-Term Assets	11.64	25.3	48.66	13.9	13.86	4.59	4.06	3.92	26.6	1.53	Upgrade
Total Assets	329.59	193.57	379.63	625.64	163.01	83.62	97.38	54.78	113.47	86.75	Upgrade
Accounts Payable	38.47	42.02	51.29	37.01	30.04	36.38	25.88	15.27	9.35	3.99	Upgrade
Deferred Revenue	6.02	0.31	0.46	0.61	0.76	0.91	1.22	1.37	1.52	1.68	Upgrade
Current Debt	0	0	0.98	22.18	0	0	0.13	0.07	0.21	0.28	Upgrade
Other Current Liabilities	9.23	10.88	12.66	27.75	53.65	1.56	0.73	0.17	-0.55	-0.82	Upgrade
Total Current Liabilities	53.72	53.2	65.38	87.55	84.45	38.85	27.96	16.88	10.53	5.12	Upgrade
Long-Term Debt	109.35	81.48	76.64	18.13	39.19	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	6.02	0.31	0.46	0.61	0.76	20.73	2.43	2.04	1.37	1.52	Upgrade
Total Long-Term Liabilities	115.37	81.78	77.09	18.74	39.95	20.73	2.43	2.04	1.37	1.52	Upgrade
Total Liabilities	169.09	134.99	142.48	106.29	124.4	59.58	30.39	18.91	11.9	6.65	Upgrade
Total Debt	109.35	81.48	77.61	40.31	39.19	0	0.13	0.07	0.21	0.28	Upgrade
Debt Growth	34.21%	4.99%	92.55%	2.86%	-	-	85.84%	-67.44%	-23.13%	-62.93%	Upgrade
Retained Earnings	-1,514.36	-1,527.03	-1,328.7	-980.6	-701.22	-528.35	-354.86	-236.39	-158.13	-95.19	Upgrade
Shareholders' Equity	160.5	58.59	237.15	519.35	38.62	24.04	66.99	35.87	101.57	80.1	Upgrade
Net Cash / Debt	109.44	81.47	238.42	566.38	102.5	70.14	85.18	45.4	77.6	79.08	Upgrade
Net Cash / Debt Growth	34.33%	-65.83%	-57.90%	452.57%	46.13%	-17.65%	87.61%	-41.49%	-1.87%	98.97%	Upgrade
Net Cash Per Share	0.74	0.60	1.80	4.91	1.16	0.93	1.37	-	1.70	2.32	Upgrade
Working Capital	264.22	115.07	265.58	524.19	64.7	40.18	65.36	33.99	76.34	80.09	Upgrade
Book Value Per Share	1.13	0.43	1.79	4.50	0.44	0.32	1.08	0.66	2.23	2.35	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).